Engage Bio

Engage Bio, located in Santa Clara, California, is an early-stage biotech company that specializes in the healthcare sector, specifically within therapeutics. Founded in March 2022 and part of the Y-Combinator W22 batch, the company has a small team of five members. Engage Bio is pioneering in the field of synthetic biology and drug discovery by developing mRNA immunotherapies aimed at transforming cancer cells into factories that produce and release drugs to combat solid tumors. This innovative approach utilizes mRNA drugs to induce cancer cells to express immunotherapies that activate the immune system against cancer. The founders bring significant expertise to the table, with a background in developing four clinical-stage immunotherapy drugs. Engage Bio is actively hiring to expand its impact in the regions of the United States and Canada.